Jan 24 (Reuters) - Essex Bio-Technology Ltd 1061.HK :
* Tech-inside information - collaboration and license agreement and proposed
subscription of series c preferred stock and warrants 1061.HK
* Says Essex Bio investment and abpro entered into the collaboration and
license agreement
* Parties agreed to commercialise and jointly develop selected antibodies into
licensed products
* The collaboration and license agreement is for an initial term of 10 years
* Essex Bio investment and abpro entered into the share subscription agreement
* Abpro conditionally agreed to issue, 616,197 series c preferred stock for a
total consideration of approximately US$3.5 million
* Source text for Eikon ID:nHKS7J24h6
* ((For more news, please click here 1061.HK )) ((Bengaluru Newsroom; +91 80
6749 1130))